Read the receipt.
- Displayed amount
- Quote required Insurance or specialty-pharmacy quote
- Delivery route
- Injection
- Product status
- FDA-approved medicine
- Membership in this figure
- See provider inclusions and terms
- Quantity
- Confirm the exact supplied quantity
- Upfront commitment
- Confirm the initial charge and billing period
Confirm consultation, labs, shipping, supplies, cancellation and the complete initial invoice. Unspecified charges are not assumed to be zero.
Sources: Theratechnologies — EGRIFTA WR, EGRIFTA WR — prescribing information, THERA patient support
What this price means.
THERA support may help qualifying patients navigate coverage and assistance. It does not establish a price available to every reader. Ask for the actual patient responsibility, exact prescribed supply and separate clinical costs. A compounded tesamorelin quote is not a quote for this approved brand.
Sources: Theratechnologies — EGRIFTA WR, EGRIFTA WR — prescribing information, THERA patient support
The product context.
EGRIFTA WR is approved for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. Its label specifically excludes weight-loss management and says long-term cardiovascular safety has not been established. A provider listing for tesamorelin does not establish that this approved brand is supplied. Compounded preparations do not inherit its approval.
Sources: EGRIFTA WR — prescribing information, FDA — compounding questions and answers
Before you pay.
What will actually be charged today?
Confirm the initial charge and billing period. Request the full amount due today, its supply period, the next charge date and the renewal amount. The displayed price is a sourced offer, not a personalized invoice.
Is this a clinical recommendation?
No. This review covers public product and price information. Eligibility, treatment choice and the prescribed amount require an appropriate clinician. We have not tested this product.
What should I compare it with?
Start with the same ingredient, route, supplied quantity and billing term. Add any separate care or membership fees. Differences in product approval or formulation remain meaningful even when prices are similar.
Follow the evidence
Sources & price notes
Each source retains its own check date. Provider pages document advertised terms; they do not independently establish clinical outcomes.
- Theratechnologies — EGRIFTA WR ↗
Approved tesamorelin brand for excess abdominal fat in adults with HIV-associated lipodystrophy. No universal cash price was established.
Checked October 9, 2026
- EGRIFTA WR — prescribing information ↗
Label defines the indication, limitations, contraindications and monitoring requirements. EGRIFTA WR is not indicated for weight-loss management.
Checked October 9, 2026
- THERA patient support ↗
Insurance and financial-assistance support subject to eligibility. A support program is not a universal medication price.
Checked October 9, 2026
- FDA — compounding questions and answers ↗
Clinical and regulatory context. A compounded preparation is not FDA-approved.
Checked October 8, 2026